nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—CYP2A6—Methoxsalen—psoriasis	0.126	0.148	CbGbCtD
Halothane—ALB—Acitretin—psoriasis	0.0988	0.116	CbGbCtD
Halothane—CYP2A6—Prednisolone—psoriasis	0.0614	0.0718	CbGbCtD
Halothane—CYP2B6—Cholecalciferol—psoriasis	0.0544	0.0637	CbGbCtD
Halothane—ALB—Mycophenolate mofetil—psoriasis	0.0462	0.0542	CbGbCtD
Halothane—CYP2D6—Hydroxyurea—psoriasis	0.0434	0.0508	CbGbCtD
Halothane—ALB—Prednisone—psoriasis	0.037	0.0433	CbGbCtD
Halothane—CYP2A6—Dexamethasone—psoriasis	0.0362	0.0424	CbGbCtD
Halothane—CYP3A4—Calcitriol—psoriasis	0.0324	0.038	CbGbCtD
Halothane—CYP2C9—Cholecalciferol—psoriasis	0.0287	0.0337	CbGbCtD
Halothane—CYP2D6—Cholecalciferol—psoriasis	0.0263	0.0308	CbGbCtD
Halothane—CYP3A4—Methoxsalen—psoriasis	0.0252	0.0295	CbGbCtD
Halothane—CYP2E1—Dexamethasone—psoriasis	0.0239	0.028	CbGbCtD
Halothane—CYP2B6—Dexamethasone—psoriasis	0.0235	0.0276	CbGbCtD
Halothane—CYP2C9—Cyclosporine—psoriasis	0.0189	0.0221	CbGbCtD
Halothane—ALB—Methotrexate—psoriasis	0.0185	0.0217	CbGbCtD
Halothane—CYP2D6—Cyclosporine—psoriasis	0.0173	0.0202	CbGbCtD
Halothane—CYP3A4—Cholecalciferol—psoriasis	0.0167	0.0196	CbGbCtD
Halothane—CYP3A4—Triamcinolone—psoriasis	0.0145	0.017	CbGbCtD
Halothane—CYP3A4—Mycophenolate mofetil—psoriasis	0.0145	0.017	CbGbCtD
Halothane—CYP2C9—Dexamethasone—psoriasis	0.0124	0.0146	CbGbCtD
Halothane—CYP3A4—Betamethasone—psoriasis	0.0124	0.0146	CbGbCtD
Halothane—CYP3A4—Prednisolone—psoriasis	0.0123	0.0144	CbGbCtD
Halothane—CYP3A4—Hydrocortisone—psoriasis	0.0116	0.0136	CbGbCtD
Halothane—CYP3A4—Prednisone—psoriasis	0.0116	0.0136	CbGbCtD
Halothane—CYP2D6—Dexamethasone—psoriasis	0.0114	0.0133	CbGbCtD
Halothane—CYP3A4—Cyclosporine—psoriasis	0.011	0.0129	CbGbCtD
Halothane—CYP3A4—Dexamethasone—psoriasis	0.00723	0.00847	CbGbCtD
Halothane—KCNMA1—Hemostasis—ITGAL—psoriasis	0.000281	0.00193	CbGpPWpGaD
Halothane—GNG2—Hemostasis—ITGAL—psoriasis	0.00028	0.00191	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—STAT3—psoriasis	0.000277	0.00189	CbGpPWpGaD
Halothane—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000272	0.00186	CbGpPWpGaD
Halothane—ND1—Metabolism—CYP2S1—psoriasis	0.000271	0.00185	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CYP2S1—psoriasis	0.000271	0.00185	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000265	0.00181	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—LEP—psoriasis	0.000259	0.00177	CbGpPWpGaD
Halothane—RHO—G alpha (i) signalling events—CXCL8—psoriasis	0.000258	0.00177	CbGpPWpGaD
Halothane—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000255	0.00175	CbGpPWpGaD
Halothane—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000252	0.00172	CbGpPWpGaD
Halothane—GNG2—Metabolism—NDUFA5—psoriasis	0.000251	0.00172	CbGpPWpGaD
Halothane—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00025	0.00171	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	0.000247	0.00169	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—NOS2—psoriasis	0.000242	0.00165	CbGpPWpGaD
Halothane—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000238	0.00163	CbGpPWpGaD
Halothane—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000237	0.00162	CbGpPWpGaD
Halothane—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000236	0.00162	CbGpPWpGaD
Halothane—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000235	0.00161	CbGpPWpGaD
Halothane—GNG2—Transmembrane transport of small molecules—CP—psoriasis	0.000234	0.0016	CbGpPWpGaD
Halothane—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000233	0.00159	CbGpPWpGaD
Halothane—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000231	0.00158	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCL20—psoriasis	0.000226	0.00155	CbGpPWpGaD
Halothane—RHO—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000226	0.00155	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—PPARG—psoriasis	0.000226	0.00155	CbGpPWpGaD
Halothane—GNG2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000223	0.00153	CbGpPWpGaD
Halothane—ALB—Hemostasis—SERPINB8—psoriasis	0.000222	0.00152	CbGpPWpGaD
Halothane—GNG2—Metabolism—CYP2S1—psoriasis	0.000214	0.00146	CbGpPWpGaD
Halothane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	0.000212	0.00145	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.000205	0.00141	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—TNF—psoriasis	0.000205	0.00141	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CXCL8—psoriasis	0.000202	0.00138	CbGpPWpGaD
Halothane—NPSR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000201	0.00138	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HCAR2—psoriasis	0.000198	0.00135	CbGpPWpGaD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—JUN—psoriasis	0.000196	0.00134	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CCL20—psoriasis	0.000191	0.00131	CbGpPWpGaD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	0.000189	0.00129	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—CAT—psoriasis	0.000186	0.00128	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.000186	0.00128	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—CRP—psoriasis	0.000182	0.00125	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—TP53—psoriasis	0.000181	0.00124	CbGpPWpGaD
Halothane—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	0.000181	0.00124	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—APOE—psoriasis	0.000178	0.00122	CbGpPWpGaD
Halothane—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000176	0.0012	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCL20—psoriasis	0.000176	0.0012	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CCL20—psoriasis	0.000174	0.00119	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TAGAP—psoriasis	0.000171	0.00117	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL4—psoriasis	0.000171	0.00117	CbGpPWpGaD
Halothane—GABRQ—Transmembrane transport of small molecules—CP—psoriasis	0.00017	0.00116	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000167	0.00115	CbGpPWpGaD
Halothane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000166	0.00114	CbGpPWpGaD
Halothane—GABRQ—Transmembrane transport of small molecules—CARM1—psoriasis	0.000162	0.00111	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—JUN—psoriasis	0.00016	0.0011	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—CXCL8—psoriasis	0.000156	0.00107	CbGpPWpGaD
Halothane—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000156	0.00107	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	0.000155	0.00106	CbGpPWpGaD
Halothane—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000154	0.00105	CbGpPWpGaD
Halothane—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000151	0.00104	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—CXCL8—psoriasis	0.000151	0.00103	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—CAT—psoriasis	0.000148	0.00101	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—CRP—psoriasis	0.000148	0.00101	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—NFKBIA—psoriasis	0.000147	0.00101	CbGpPWpGaD
Halothane—GABRG3—Transmembrane transport of small molecules—CP—psoriasis	0.00014	0.000959	CbGpPWpGaD
Halothane—GABRB1—Transmembrane transport of small molecules—CP—psoriasis	0.000138	0.000944	CbGpPWpGaD
Halothane—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000137	0.000941	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—ICAM1—psoriasis	0.000136	0.000932	CbGpPWpGaD
Halothane—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000134	0.00092	CbGpPWpGaD
Halothane—GABRG3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000134	0.000915	CbGpPWpGaD
Halothane—ND1—Metabolism—CARM1—psoriasis	0.000132	0.000906	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CARM1—psoriasis	0.000132	0.000906	CbGpPWpGaD
Halothane—GABRB1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000132	0.000901	CbGpPWpGaD
Halothane—GABRA6—Transmembrane transport of small molecules—CP—psoriasis	0.00013	0.000894	CbGpPWpGaD
Halothane—GNG2—Platelet activation, signaling and aggregation—VEGFA—psoriasis	0.000129	0.000882	CbGpPWpGaD
Halothane—GABRA4—Transmembrane transport of small molecules—CP—psoriasis	0.000129	0.000882	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	0.000127	0.000872	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—SOCS1—psoriasis	0.000125	0.000854	CbGpPWpGaD
Halothane—GABRA6—Transmembrane transport of small molecules—CARM1—psoriasis	0.000124	0.000852	CbGpPWpGaD
Halothane—GABRA4—Transmembrane transport of small molecules—CARM1—psoriasis	0.000123	0.000842	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—TYK2—psoriasis	0.000119	0.000814	CbGpPWpGaD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.000118	0.000811	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	0.000118	0.000807	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—CRP—psoriasis	0.000118	0.000805	CbGpPWpGaD
Halothane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000116	0.000793	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—NOS2—psoriasis	0.000115	0.00079	CbGpPWpGaD
Halothane—GNG2—Hemostasis—NOS2—psoriasis	0.000115	0.000785	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—CP—psoriasis	0.000114	0.000784	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—CXCL8—psoriasis	0.000114	0.000781	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—CP—psoriasis	0.000112	0.00077	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000112	0.00077	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	0.00011	0.000757	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—CP—psoriasis	0.00011	0.000752	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—CARM1—psoriasis	0.000109	0.000748	CbGpPWpGaD
Halothane—RHO—Disease—HLA-A—psoriasis	0.000109	0.000747	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	0.000108	0.00074	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	0.000108	0.000738	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000107	0.000734	CbGpPWpGaD
Halothane—ALB—SLC-mediated transmembrane transport—CP—psoriasis	0.000106	0.000727	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000106	0.000725	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—TP53—psoriasis	0.000106	0.000724	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000105	0.000722	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—CARM1—psoriasis	0.000105	0.000717	CbGpPWpGaD
Halothane—GNG2—Metabolism—CARM1—psoriasis	0.000104	0.000715	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IFNG—psoriasis	0.000104	0.000709	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CXCL8—psoriasis	0.000104	0.000709	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000103	0.000704	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCL20—psoriasis	0.000103	0.000703	CbGpPWpGaD
Halothane—RHO—Disease—APOE—psoriasis	0.000102	0.000698	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—JUN—psoriasis	9.76e-05	0.000668	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—IL6—psoriasis	9.68e-05	0.000663	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—SOCS1—psoriasis	9.67e-05	0.000662	CbGpPWpGaD
Halothane—RHO—Disease—NOS2—psoriasis	9.49e-05	0.00065	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	9.42e-05	0.000645	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—NFKB1—psoriasis	9.39e-05	0.000643	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—TYK2—psoriasis	9.22e-05	0.000631	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—APOE—psoriasis	9.2e-05	0.00063	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—LEP—psoriasis	9.2e-05	0.00063	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CXCL8—psoriasis	9.15e-05	0.000626	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	9.11e-05	0.000624	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	8.99e-05	0.000615	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CXCL8—psoriasis	8.84e-05	0.000605	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—NFKB1—psoriasis	8.62e-05	0.00059	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—NFKBIA—psoriasis	8.57e-05	0.000587	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—NDUFA5—psoriasis	8.54e-05	0.000585	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	8.45e-05	0.000579	CbGpPWpGaD
Halothane—GABRB3—BDNF signaling pathway—STAT3—psoriasis	8.44e-05	0.000578	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—TNF—psoriasis	8.24e-05	0.000564	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IFNG—psoriasis	8.23e-05	0.000563	CbGpPWpGaD
Halothane—ND1—Metabolism—CAT—psoriasis	8.13e-05	0.000557	CbGpPWpGaD
Halothane—ATP5D—Metabolism—CAT—psoriasis	8.13e-05	0.000557	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CXCL8—psoriasis	8.03e-05	0.00055	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	7.86e-05	0.000538	CbGpPWpGaD
Halothane—RHO—Disease—TYK2—psoriasis	7.78e-05	0.000533	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.56e-05	0.000518	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CYP2S1—psoriasis	7.26e-05	0.000497	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—LEP—psoriasis	7.13e-05	0.000489	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—APOE—psoriasis	7.13e-05	0.000489	CbGpPWpGaD
Halothane—RHO—Disease—CD4—psoriasis	7.03e-05	0.000482	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TYK2—psoriasis	7.02e-05	0.000481	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—NDUFA5—psoriasis	6.89e-05	0.000472	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	6.86e-05	0.00047	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	6.84e-05	0.000469	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—NDUFA5—psoriasis	6.75e-05	0.000462	CbGpPWpGaD
Halothane—ALB—Platelet degranulation—VEGFA—psoriasis	6.7e-05	0.000459	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—TNF—psoriasis	6.7e-05	0.000459	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—VEGFA—psoriasis	6.68e-05	0.000458	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—NFKBIA—psoriasis	6.65e-05	0.000455	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IL6—psoriasis	6.65e-05	0.000455	CbGpPWpGaD
Halothane—GNG2—Hemostasis—VEGFA—psoriasis	6.64e-05	0.000455	CbGpPWpGaD
Halothane—ALB—Hemostasis—ITGAL—psoriasis	6.45e-05	0.000442	CbGpPWpGaD
Halothane—GNG2—Metabolism—CAT—psoriasis	6.42e-05	0.00044	CbGpPWpGaD
Halothane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	6.39e-05	0.000437	CbGpPWpGaD
Halothane—ND1—Metabolism—APOE—psoriasis	6.32e-05	0.000433	CbGpPWpGaD
Halothane—ATP5D—Metabolism—APOE—psoriasis	6.32e-05	0.000433	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CXCL8—psoriasis	6.12e-05	0.000419	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—TP53—psoriasis	5.91e-05	0.000405	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	5.88e-05	0.000403	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CYP2S1—psoriasis	5.86e-05	0.000401	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—IL6—psoriasis	5.81e-05	0.000398	CbGpPWpGaD
Halothane—ALB—Metabolism—NDUFA5—psoriasis	5.8e-05	0.000397	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CYP2S1—psoriasis	5.74e-05	0.000393	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—JUN—psoriasis	5.68e-05	0.000389	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—SOCS1—psoriasis	5.65e-05	0.000387	CbGpPWpGaD
Halothane—ND1—Metabolism—PPARG—psoriasis	5.51e-05	0.000377	CbGpPWpGaD
Halothane—ATP5D—Metabolism—PPARG—psoriasis	5.51e-05	0.000377	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—NFKB1—psoriasis	5.47e-05	0.000375	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TYK2—psoriasis	5.45e-05	0.000373	CbGpPWpGaD
Halothane—RHO—Disease—STAT3—psoriasis	5.45e-05	0.000373	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.41e-05	0.00037	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL6—psoriasis	5.41e-05	0.00037	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—CP—psoriasis	5.39e-05	0.000369	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—TYK2—psoriasis	5.39e-05	0.000369	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—TNF—psoriasis	5.32e-05	0.000365	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CXCL8—psoriasis	5.17e-05	0.000354	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	5.14e-05	0.000352	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—TP53—psoriasis	5.05e-05	0.000346	CbGpPWpGaD
Halothane—GNG2—Hemostasis—TP53—psoriasis	5.02e-05	0.000344	CbGpPWpGaD
Halothane—GNG2—Metabolism—APOE—psoriasis	4.99e-05	0.000342	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—VEGFA—psoriasis	4.97e-05	0.00034	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP2S1—psoriasis	4.93e-05	0.000338	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—STAT3—psoriasis	4.92e-05	0.000337	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NDUFA5—psoriasis	4.79e-05	0.000328	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NDUFA5—psoriasis	4.75e-05	0.000325	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	4.75e-05	0.000325	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CXCL8—psoriasis	4.74e-05	0.000325	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CXCL8—psoriasis	4.69e-05	0.000321	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—IL6—psoriasis	4.51e-05	0.000309	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.43e-05	0.000303	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—JUN—psoriasis	4.41e-05	0.000302	CbGpPWpGaD
Halothane—GNG2—Metabolism—PPARG—psoriasis	4.35e-05	0.000298	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IL6—psoriasis	4.3e-05	0.000294	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—NFKB1—psoriasis	4.24e-05	0.000291	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—LEP—psoriasis	4.17e-05	0.000286	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—APOE—psoriasis	4.17e-05	0.000286	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP2S1—psoriasis	4.07e-05	0.000279	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP2S1—psoriasis	4.04e-05	0.000277	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NFKBIA—psoriasis	3.89e-05	0.000266	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—VEGFA—psoriasis	3.85e-05	0.000264	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—STAT3—psoriasis	3.81e-05	0.000261	CbGpPWpGaD
Halothane—RHO—Disease—IL6—psoriasis	3.8e-05	0.00026	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TP53—psoriasis	3.75e-05	0.000257	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CARM1—psoriasis	3.55e-05	0.000243	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL6—psoriasis	3.43e-05	0.000235	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TYK2—psoriasis	3.18e-05	0.000218	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NDUFA5—psoriasis	3.13e-05	0.000214	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.97e-05	0.000204	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TP53—psoriasis	2.91e-05	0.000199	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CARM1—psoriasis	2.86e-05	0.000196	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CARM1—psoriasis	2.8e-05	0.000192	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CXCL8—psoriasis	2.77e-05	0.00019	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL6—psoriasis	2.66e-05	0.000182	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP2S1—psoriasis	2.66e-05	0.000182	CbGpPWpGaD
Halothane—ALB—Hemostasis—NOS2—psoriasis	2.65e-05	0.000181	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL6—psoriasis	2.64e-05	0.000181	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.59e-05	0.000177	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—JUN—psoriasis	2.58e-05	0.000177	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NFKB1—psoriasis	2.48e-05	0.00017	CbGpPWpGaD
Halothane—ALB—Metabolism—CARM1—psoriasis	2.41e-05	0.000165	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.25e-05	0.000154	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—VEGFA—psoriasis	2.25e-05	0.000154	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—STAT3—psoriasis	2.23e-05	0.000153	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CAT—psoriasis	2.18e-05	0.000149	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.12e-05	0.000145	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CARM1—psoriasis	1.99e-05	0.000136	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CARM1—psoriasis	1.97e-05	0.000135	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.84e-05	0.000126	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CAT—psoriasis	1.76e-05	0.000121	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CAT—psoriasis	1.72e-05	0.000118	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TP53—psoriasis	1.7e-05	0.000117	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—APOE—psoriasis	1.7e-05	0.000116	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL6—psoriasis	1.56e-05	0.000107	CbGpPWpGaD
Halothane—ALB—Hemostasis—VEGFA—psoriasis	1.53e-05	0.000105	CbGpPWpGaD
Halothane—ALB—Metabolism—CAT—psoriasis	1.48e-05	0.000101	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PPARG—psoriasis	1.48e-05	0.000101	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—APOE—psoriasis	1.37e-05	9.37e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—APOE—psoriasis	1.34e-05	9.17e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CARM1—psoriasis	1.3e-05	8.91e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CAT—psoriasis	1.22e-05	8.38e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CAT—psoriasis	1.21e-05	8.31e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PPARG—psoriasis	1.19e-05	8.16e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PPARG—psoriasis	1.17e-05	7.99e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—TP53—psoriasis	1.16e-05	7.93e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—APOE—psoriasis	1.15e-05	7.89e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PPARG—psoriasis	1e-05	6.87e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—APOE—psoriasis	9.51e-06	6.51e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—APOE—psoriasis	9.43e-06	6.45e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PPARG—psoriasis	8.28e-06	5.67e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PPARG—psoriasis	8.21e-06	5.62e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CAT—psoriasis	8e-06	5.48e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—APOE—psoriasis	6.22e-06	4.26e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PPARG—psoriasis	5.41e-06	3.71e-05	CbGpPWpGaD
